The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis

Arthritis and Rheumatism

Volumn 41, Issue 3, 1998, Pages 466-469

  Menon, N ^a   McAlpine, L ^b   Peacock, A J ^b   Madhok, R ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTACYCLIN;

ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; HEART CATHETERIZATION; HEMODYNAMIC MONITORING; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG BLOOD VESSEL; LUNG PRESSURE; LUNG VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SURVIVAL; SYSTEMIC SCLEROSIS;

ADULT; EPOPROSTENOL; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION, PULMONARY; INJECTIONS, INTRAVENOUS; MIDDLE AGED; PULMONARY CIRCULATION; SCLERODERMA, SYSTEMIC; VASODILATOR AGENTS;

EID: 0031909559     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199803)41:3<466::AID-ART13>3.0.CO;2-O     Document Type: Article

References (15)

1. Altman RD, Medsger, TA Jr, Bloch DA, Michel BA. Predictors of survival in systemic sclerosis (scleroderma). Arthritis Rheum 1991;34:403-13.
2. Alton E, Turner Warwick M. Lung involvement in scleroderma. In: Jason MIV, Black CM, editors. Systemic sclerosis: scleroderma. London: John Wiley & Sons; 1988. p. 188-205.
3. Ungerer RH, Tashkin DP, Furst D, Clements PJ, Gong H, Bein M, et al. Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis (scleroderma). Am J Med 1983;75:65-74.
4. Stupi AM, Steen VD, Owens GR, Barnes EL, Rodnan GP, Medsger TA Jr. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum 1986;29:515-24.
5. De la Mata J, Gomez-Sanchez MA, Aranzana M, Gomez-Reino JJ. Long-term iloprost infusion therapy for severe pulmonary hypertension in patients with connective tissue diseases. Arthritis Rheum 1994;37:1528-33.
6. Barst RJ, Rubin LJ, Long WA, McGoon MD, Rich S, Badesch DB, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 1996;334:296-301.
7. Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium channel blockers on survival in primary pulmonary hypertension N Engl J Med 1992;377:76-81.
8. Groves BM, Badesch DB, Turkevich D, Ditchey RV, Donnellan K, Wynne K, et al. Correlation of acute prostacyclin response in primary (unexplained) pulmonary hypertension with efficacy of treatment with calcium channel blockers and survival. In: Hume JR, Reeves JT, Weir EK, editors. Ion flux in pulmonary vascular control. New York: Plenum Press; 1993. p. 317-30.
9. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
10. Bartram SA, Denton CP, du Bois RM, Black CM. Use of intravenous prostacyclin to treat pulmonary hypertension associated with systemic sclerosis [abstract]. Br J Rheumatol 1995;34 Suppl 1:30.
11. Olscheewski H, Walmror D, Schermn R, Ghofrani A, Grimminger F, Seeger W. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension. Ann Intern Med 1996;124:820-4.
12. Alpert MA, Pressly TA, Mukerji V, Lambert CR, Muerji B, Panayiotou H, et al. Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease. Am J Cardiol 1991;68:1687-91.
13. Sfikakis PP, Kyriakidis MK, Vergos CG, Vyssoulis GP, Psarros TK, Kyriakidis CA, et al. Cardiopulmonary hemodynamics in systemic sclerosis and response to nifedipine and captopril. Am J Med 1991;90:541-6.
14. Morgan JM, Griffiths M, du Bois RM, Evans TM. Hypoxic pulmonary vascoconstriction in systemic sclerosis and primary pulmonary hypertension. Chest 1991;99:551-6.
15. Steen VD, Graham G, Conte C, Owens G, Medsger TA Jr. Isolated diffusing capacity reduction in systemic sclerosis. Arthritis Rheum 1992;35:765-70.